Bio-Pharmaceutical complex wages war against respiratory syncytial virus
Update: 2024-01-09
Description
The McCullough Report with Dr. Peter McCullough – As ambient aerosolized RSV virions are present in hospitals, clinics, and homes, the monoclonal antibody may backfire and enable the inhaled virion to gain access to the bronchial epithelial lining and cause worse bronchiolitis than the baby would have with their own developing natural immunity. This would explain why the efficacy for RSV hospitalization was NOT compelling from the two RCTs of Nirsevimab...
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
1.0x
